Companies / Germany
Boehringer Japan Outpaces Competitors In 2005
April 2006 | Company Finance AlertElsewhere, Chugai, the Japanese affiliate of Swiss pharmaceutical major Roche, has filed a submission for colorectal cancer drug Avastin (bevacizumab) with the health ministry. A new ministry committee is expected to fast-track the drug, based on EU and US Phase II/III trial data. The panel recently received a submission for non-small cell lung cancer drug Tarceva from Genentech.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
